
### [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086)
**Label:** Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 53.92%
- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 52.08%
- [NCIT:C90529](http://purl.obolibrary.org/obo/NCIT_C90529) (AJCC v6 Stage) 52.08%
- [NCIT:C27966](http://purl.obolibrary.org/obo/NCIT_C27966) (Stage I) 52.08%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 37.44%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 37.44%


